Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Total Liabilities (2016 - 2026)

Healthstream has reported Total Liabilities over the past 16 years, most recently at $166.4 million for Q4 2025.

  • Quarterly Total Liabilities rose 9.87% to $166.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $166.4 million through Dec 2025, up 9.87% year-over-year, with the annual reading at $166.4 million for FY2025, 9.87% up from the prior year.
  • Total Liabilities was $166.4 million for Q4 2025 at Healthstream, up from $150.7 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $167.1 million in Q1 2023 and troughed at $147.4 million in Q3 2024.
  • The 5-year median for Total Liabilities is $154.3 million (2023), against an average of $156.3 million.
  • The largest YoY upside for Total Liabilities was 145.94% in 2021 against a maximum downside of 11.14% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $147.7 million in 2021, then rose by 10.79% to $163.7 million in 2022, then decreased by 2.74% to $159.2 million in 2023, then dropped by 4.89% to $151.4 million in 2024, then grew by 9.87% to $166.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Total Liabilities are $166.4 million (Q4 2025), $150.7 million (Q3 2025), and $149.6 million (Q2 2025).